Global Hospital Injectable Drugs Market Growth (Status and Outlook) 2023-2029

Global Hospital Injectable Drugs Market Growth (Status and Outlook) 2023-2029

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
LPI (LP Information)' newest research report, the “Hospital Injectable Drugs Industry Forecast” looks at past sales and reviews total world Hospital Injectable Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Hospital Injectable Drugs sales for 2023 through 2029. With Hospital Injectable Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hospital Injectable Drugs industry.
This Insight Report provides a comprehensive analysis of the global Hospital Injectable Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hospital Injectable Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hospital Injectable Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hospital Injectable Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hospital Injectable Drugs.
The global Hospital Injectable Drugs market size is projected to grow from US$ 39530 million in 2022 to US$ 55550 million in 2029; it is expected to grow at a CAGR of 5.0% from 2023 to 2029.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Injectable Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Segmentation by application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Hospital Injectable Drugs Market Size by Player
4 Hospital Injectable Drugs by Regions
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Hospital Injectable Drugs Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings